A Randomised Controlled Trial of Prostar PlusTMfor Haemostasis in Patients After Coronary Angioplasty

A Randomised Controlled Trial of Prostar PlusTMfor Haemostasis in Patients After Coronary Angioplasty

Objectives: to clarify the efficacy and safety of Prostar PlusTM, a new percutaneous vascular surgical device (PVS) for vascular haemostasis. Design: prospective randomised controlled trial. Methods: a consecutive series of 60 patients were randomised to either PVS (n =30) or conventional manual com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of vascular and endovascular surgery 2000-05, Vol.19 (5), p.451-455
Hauptverfasser: Noguchi, T, Miyazaki, S, Yasuda, S, Baba, T, Sumida, H, Morii, I, Daikoku, S, Goto, Y, Nonogi, H
Format: Artikel
Sprache:eng
Schlagworte:
Angioplasty
Catheterisation
Complications
Percutaneous vascular surgical device
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives: to clarify the efficacy and safety of Prostar PlusTM, a new percutaneous vascular surgical device (PVS) for vascular haemostasis. Design: prospective randomised controlled trial. Methods: a consecutive series of 60 patients were randomised to either PVS (n =30) or conventional manual compression ( n=30) following coronary angioplasty or stenting with femoral access using an 8-F sheath. Results: PVS significantly shortened the time to haemostasis (10 s.d. 3 vs. 27 s.d. 9 min, p
ISSN:1078-5884
1532-2165
DOI:10.1053/ejvs.1999.1071